Navigation Links
Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology

What: A two-day workshop hosted by the National Nanotechnology Initiative (NNI) and the Oregon Nanoscience and Microtechnologies Institute (ONAMI) to assess the current landscape of regional, state, and local (RSL) nanotechnology initiatives.

When: May 1-2, 2012, with optional site visits on April 30

Where: Portland, Oregon at the Embassy SuitesDowntown, located at 319 SW Pine Street, Portland, OR

Who: Leaders of regional, state, and local organizations and the Federal government; economic development groups; investors and entrepreneurs; technology leaders; and scientists and engineers from industry, business, government, academia, and the general public.

Why: To interface with regional, state, and local bodies as the NNI enters its second decade, with a focus on economic growth and job creation, and the tech transfer and commercialization of nanotechnology potential applications.

How: The workshop will examine:

  • the current landscape of U.S. RSL nanotechnology initiatives and their status;
  • current Federal resources available for RSLs;
  • RSL best practices, business models, and opportunities for partnering; and
  • the role of nanotechnology RSLs in future U.S. economic growth and job creation.

Confirmed speakers include Dr. Clayton Teague, former NNCO Director; Don Kania, President and CEO of FEI; Ted Wheeler, Oregon State Treasurer; Tim Harper, Technology Entrepreneur and Owner of Cientifica; Mark Skinner, Vice President of State Science and Technology Institute (SSTI); Vincent Caprio, Executive Director of the NanoBusiness Commercialization Assocation; Travis Earles, Senior Manager of Advanced Materials & Nanotechnology Initiatives at Lockheed Martin; Mary Jo Waits, Director of Economic, Human Services & Workforce Division at the National Governors Association; and Jim Mason, Executive Director of the Oklahoma Nanotechnology Initiative.

Contact: Marlowe Epstein
National Nanotechnology Coordination Office

Related biology technology :

1. Stem Cell Assurance Announces the Filing of Its Form 10 Registration Statement
2. SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy
3. Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration
4. Registration Open for WBBAs Life Science Innovation Northwest 2011 Event Webcast
5. Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
6. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
7. LS9's UltraClean Diesel™ Receives EPA Registration
8. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
9. Dempsey Challenge Participant Registration Officially Open
10. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
11. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):